FDA Requiring Stronger Safety Labels for Opioid Medications
Updated opioid safety labeling is based on new data from two large postmarketing observational studiesContinue Reading
Updated opioid safety labeling is based on new data from two large postmarketing observational studiesContinue Reading
THURSDAY, July 31, 2025 (HealthDay News) — State bans on enticing flavors of e-cigarettes bring real benefits in terms of lowering vaping among adults of any age, new research finds. But it points to a downside, too: A slowdown in statewide declines of cigarette smoking after flavored vapes were banned. Continue Reading
FRIDAY, July 25, 2025 (HealthDay News) — It’s official: The controversial preservative thimerosal will be stripped from all flu vaccines distributed in the United States. U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. signed off on the recommendation from an expert panel that recommended removing the mercury-based preservative from all influenza vaccines. UseContinue Reading
FRIDAY, July 25, 2025 (HealthDay News) — Veterans who receive traumatic brain injuries in combat often experience crippling post-traumatic stress disorder, anxiety and depression, leaving them hopeless and potentially suicidal. But help might be on the way from an unlikely source – a psychedelic drug called ibogaine. The drug, derivedContinue Reading
Tidmarsh’s areas of expertise include pediatrics, pediatric oncology, and neonatologyContinue Reading
WEDNESDAY, July 23, 2025 (HealthDay News) — Urgent care clinics are handing out fistfuls of antibiotics, steroids and opioids for conditions these drugs won’t help, a new study says. “Previous studies had shown that patients continue to receive antibiotics for diagnoses where they may not be indicated, such as forContinue Reading
Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine processContinue Reading
FRIDAY, July 18, 2025 (HealthDay News) — Hives can drive a person crazy, covering parts of the body with maddeningly itchy welts. Now, a new evidence review has identified the most effective treatments for people who suffer from chronic hives. The injectable antibody drug omalizumab and a yet-to-be-approved pill calledContinue Reading
THURSDAY, July 17, 2025 (HealthDay News) — A new antibody shot that protects babies against RSV infection could be struggling to gain traction, researchers report. Only about a third (35%) of babies eligible for nirsevimab got the injection during the 2023-24 RSV season, researchers reported today in the journal Pediatrics.Continue Reading
However, improvements seen in vaccination rates for diphtheria-tetanus-pertussis, measles, HPVContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.